Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 10 | 2021 | 1221 | 0.970 |
Why?
|
| Brain Ischemia | 7 | 2021 | 420 | 0.640 |
Why?
|
| Brain | 5 | 2019 | 1625 | 0.630 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2012 | 186 | 0.430 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2021 | 166 | 0.420 |
Why?
|
| Carotid Stenosis | 2 | 2012 | 100 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 2262 | 0.400 |
Why?
|
| Middle Cerebral Artery | 1 | 2012 | 51 | 0.360 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2012 | 98 | 0.360 |
Why?
|
| Carotid Artery, Internal | 1 | 2012 | 69 | 0.360 |
Why?
|
| Cerebral Angiography | 6 | 2017 | 303 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2011 | 1662 | 0.280 |
Why?
|
| Astronauts | 2 | 2019 | 7 | 0.260 |
Why?
|
| Weightlessness | 2 | 2019 | 12 | 0.260 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2017 | 67 | 0.200 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2011 | 62 | 0.160 |
Why?
|
| Stents | 2 | 2017 | 501 | 0.150 |
Why?
|
| Space Flight | 1 | 2019 | 20 | 0.140 |
Why?
|
| Male | 15 | 2019 | 31298 | 0.140 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2017 | 3 | 0.130 |
Why?
|
| Arthritis, Juvenile | 1 | 2017 | 7 | 0.130 |
Why?
|
| White Matter | 1 | 2019 | 128 | 0.130 |
Why?
|
| Synovitis | 1 | 2017 | 30 | 0.130 |
Why?
|
| Suction | 1 | 2017 | 34 | 0.130 |
Why?
|
| Aged | 11 | 2017 | 15090 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 83 | 0.120 |
Why?
|
| Female | 13 | 2019 | 34311 | 0.120 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2015 | 2 | 0.120 |
Why?
|
| Atlanto-Axial Joint | 1 | 2015 | 3 | 0.120 |
Why?
|
| Time Factors | 3 | 2014 | 3777 | 0.120 |
Why?
|
| Multidetector Computed Tomography | 1 | 2015 | 22 | 0.110 |
Why?
|
| Humans | 19 | 2021 | 65655 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 188 | 0.110 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2015 | 6 | 0.110 |
Why?
|
| Optic Nerve | 1 | 2015 | 29 | 0.110 |
Why?
|
| Spinal Fractures | 2 | 2015 | 41 | 0.110 |
Why?
|
| Collateral Circulation | 1 | 2014 | 28 | 0.110 |
Why?
|
| Thrombectomy | 1 | 2017 | 263 | 0.110 |
Why?
|
| Thrombolytic Therapy | 2 | 2012 | 204 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 184 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2011 | 278 | 0.100 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1172 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2017 | 5820 | 0.090 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2012 | 126 | 0.080 |
Why?
|
| Creatine | 1 | 2011 | 23 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 1715 | 0.080 |
Why?
|
| Vertebroplasty | 1 | 2010 | 8 | 0.080 |
Why?
|
| Fractures, Compression | 1 | 2010 | 9 | 0.080 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2010 | 9 | 0.080 |
Why?
|
| Acute Disease | 2 | 2009 | 663 | 0.080 |
Why?
|
| Brain Stem | 1 | 2010 | 30 | 0.080 |
Why?
|
| Minocycline | 1 | 2010 | 28 | 0.080 |
Why?
|
| Basilar Artery | 1 | 2010 | 34 | 0.080 |
Why?
|
| Needles | 1 | 2010 | 63 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1227 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 994 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2010 | 140 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 80 | 0.080 |
Why?
|
| Cerebral Revascularization | 1 | 2009 | 30 | 0.070 |
Why?
|
| Macaca mulatta | 1 | 2010 | 261 | 0.070 |
Why?
|
| Middle Aged | 7 | 2019 | 18440 | 0.070 |
Why?
|
| Reperfusion | 3 | 2017 | 37 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2010 | 183 | 0.070 |
Why?
|
| Europe | 1 | 2009 | 199 | 0.070 |
Why?
|
| Neurons | 2 | 2011 | 935 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2011 | 400 | 0.070 |
Why?
|
| Pain | 1 | 2010 | 400 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2021 | 6948 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 464 | 0.060 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 631 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2012 | 5657 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2327 | 0.050 |
Why?
|
| Contrast Media | 2 | 2017 | 432 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2017 | 2639 | 0.050 |
Why?
|
| Spin Labels | 1 | 2021 | 12 | 0.040 |
Why?
|
| Infarction | 1 | 2021 | 20 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 76 | 0.040 |
Why?
|
| Adult | 5 | 2019 | 17511 | 0.040 |
Why?
|
| Viral Load | 2 | 2011 | 230 | 0.040 |
Why?
|
| Young Adult | 3 | 2017 | 4855 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2011 | 606 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 174 | 0.040 |
Why?
|
| Gadolinium | 1 | 2017 | 110 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 71 | 0.030 |
Why?
|
| Occipital Bone | 1 | 2015 | 5 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2011 | 679 | 0.030 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2015 | 5 | 0.030 |
Why?
|
| Rupture | 1 | 2015 | 24 | 0.030 |
Why?
|
| Ligaments | 1 | 2015 | 9 | 0.030 |
Why?
|
| Joint Dislocations | 1 | 2015 | 18 | 0.030 |
Why?
|
| Skull Fractures | 1 | 2015 | 20 | 0.030 |
Why?
|
| United States | 1 | 2009 | 8166 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 1567 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 123 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 6350 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1163 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 160 | 0.020 |
Why?
|
| Iopamidol | 1 | 2011 | 13 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 372 | 0.020 |
Why?
|
| Macaca | 1 | 2011 | 30 | 0.020 |
Why?
|
| Choline | 1 | 2011 | 23 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 84 | 0.020 |
Why?
|
| Inositol | 1 | 2011 | 9 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 34 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2010 | 13 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2010 | 96 | 0.020 |
Why?
|
| Paresis | 1 | 2010 | 15 | 0.020 |
Why?
|
| Protons | 1 | 2010 | 67 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 709 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 2010 | 51 | 0.020 |
Why?
|
| Boston | 1 | 2010 | 260 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 213 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1335 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 61 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2010 | 61 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 664 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 371 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 898 | 0.020 |
Why?
|
| Child | 1 | 2017 | 4635 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 1120 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1116 | 0.020 |
Why?
|
| Microglia | 1 | 2010 | 254 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1432 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 1026 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 704 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 3329 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 1487 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 1226 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 2113 | 0.010 |
Why?
|
| Animals | 2 | 2011 | 21467 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 5466 | 0.010 |
Why?
|